OAKLAND, Calif. — Members of the committee created to advise the Division of Workers’ Compensation on changes to the formulary launched at the start of the year dedicated the majority of their first meeting Wednesday on discussing ways to improve usability for payers and providers.
After starting with a review of the basic principles of the California workers’ compensation drug formulary, the Pharmacy and Therapeutics Committee started discussing the role of unique product identifiers to help payers determine which medications are exempt from prospective utilization rev...
Comments